Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)

AimMetabolic syndrome (MS) refers to a group of co-morbidities which include central obesity, hypertension, hyperglycemia and dyslipidemia. Previously, we reported that childhood lymphatic filariasis (LF) confers significant protection against type-1 and type-2 forms of diabetes, by means of immunom...

Full description

Bibliographic Details
Main Authors: Joy Manohar Sibi, Viswanathan Mohan, Mohan Deepa, Subash Babu, Vivekanandhan Aravindhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1011942/full
_version_ 1811189207161372672
author Joy Manohar Sibi
Viswanathan Mohan
Mohan Deepa
Subash Babu
Vivekanandhan Aravindhan
author_facet Joy Manohar Sibi
Viswanathan Mohan
Mohan Deepa
Subash Babu
Vivekanandhan Aravindhan
author_sort Joy Manohar Sibi
collection DOAJ
description AimMetabolic syndrome (MS) refers to a group of co-morbidities which include central obesity, hypertension, hyperglycemia and dyslipidemia. Previously, we reported that childhood lymphatic filariasis (LF) confers significant protection against type-1 and type-2 forms of diabetes, by means of immunomodulation. In the present study, we studied the effect of LF on endocrine dysfunction in MS and Non-MS patients in baseline and after 10 years of follow-up.MethodsWe quantified the serum levels of pancreatic hormones (insulin and glucagon), incretins (Ghrelin, GIP and GLP-1) and adipokines (leptin, adiponectin, adipsin, visfatin, PAI-1 and resistin) by multiplex bead array system.ResultsMS (both LF- and LF+) subjects had increased insulin levels compared to NMS (both LF- and LF+) subjects. MS-LF+ subjects had significantly increased levels of glucagon, ghrelin, GIP and GLP-1 and decreased levels of adipsin, compared to MS-LF- subjects. Interestingly this effect was short-lived and was not seen in the follow-up samples.ConclusionOverall, LF infection might confer limited short-term beneficial effects against MS, by means of modulating the incretin levels,either directly or indirectly.
first_indexed 2024-04-11T14:31:59Z
format Article
id doaj.art-6e1050c694154378be7989a772183d73
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T14:31:59Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-6e1050c694154378be7989a772183d732022-12-22T04:18:34ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-11-011310.3389/fendo.2022.10119421011942Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)Joy Manohar Sibi0Viswanathan Mohan1Mohan Deepa2Subash Babu3Vivekanandhan Aravindhan4Department of Genetics, Dr. A. L. Mudaliar Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, IndiaMadras Diabetes Research Foundation and Dr. Mohan’s Diabetes Specialties Centre, ICMR Center for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes Care, Chennai, IndiaMadras Diabetes Research Foundation and Dr. Mohan’s Diabetes Specialties Centre, ICMR Center for Advanced Research on Diabetes and IDF Centre of Excellence in Diabetes Care, Chennai, IndiaNational Institute of Health-International Centre for Excellence in Research, National Institute for Research in Tuberculosis, Chennai, IndiaDepartment of Genetics, Dr. A. L. Mudaliar Post Graduate Institute of Basic Medical Sciences, University of Madras, Chennai, IndiaAimMetabolic syndrome (MS) refers to a group of co-morbidities which include central obesity, hypertension, hyperglycemia and dyslipidemia. Previously, we reported that childhood lymphatic filariasis (LF) confers significant protection against type-1 and type-2 forms of diabetes, by means of immunomodulation. In the present study, we studied the effect of LF on endocrine dysfunction in MS and Non-MS patients in baseline and after 10 years of follow-up.MethodsWe quantified the serum levels of pancreatic hormones (insulin and glucagon), incretins (Ghrelin, GIP and GLP-1) and adipokines (leptin, adiponectin, adipsin, visfatin, PAI-1 and resistin) by multiplex bead array system.ResultsMS (both LF- and LF+) subjects had increased insulin levels compared to NMS (both LF- and LF+) subjects. MS-LF+ subjects had significantly increased levels of glucagon, ghrelin, GIP and GLP-1 and decreased levels of adipsin, compared to MS-LF- subjects. Interestingly this effect was short-lived and was not seen in the follow-up samples.ConclusionOverall, LF infection might confer limited short-term beneficial effects against MS, by means of modulating the incretin levels,either directly or indirectly.https://www.frontiersin.org/articles/10.3389/fendo.2022.1011942/fullmetabolic syndromefilariasisincretinsadipokinesinsulinglucagon
spellingShingle Joy Manohar Sibi
Viswanathan Mohan
Mohan Deepa
Subash Babu
Vivekanandhan Aravindhan
Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)
Frontiers in Endocrinology
metabolic syndrome
filariasis
incretins
adipokines
insulin
glucagon
title Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)
title_full Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)
title_fullStr Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)
title_full_unstemmed Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)
title_short Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5)
title_sort modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome dm lf5
topic metabolic syndrome
filariasis
incretins
adipokines
insulin
glucagon
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1011942/full
work_keys_str_mv AT joymanoharsibi modulatoryeffectoffilarialinfectiononthesystemichormonelevelsinsubjectswithmetabolicsyndromedmlf5
AT viswanathanmohan modulatoryeffectoffilarialinfectiononthesystemichormonelevelsinsubjectswithmetabolicsyndromedmlf5
AT mohandeepa modulatoryeffectoffilarialinfectiononthesystemichormonelevelsinsubjectswithmetabolicsyndromedmlf5
AT subashbabu modulatoryeffectoffilarialinfectiononthesystemichormonelevelsinsubjectswithmetabolicsyndromedmlf5
AT vivekanandhanaravindhan modulatoryeffectoffilarialinfectiononthesystemichormonelevelsinsubjectswithmetabolicsyndromedmlf5